The Washington legislature directed the medical associations in the state to develop opioid prescribing guidelines for their professions by 2019. This 4 page document briefly explains the guidelines developed for osteopathic physicians and osteopathic physician assistants.
Funding Source: Washington State Department of Health
The Washington legislature directed the medical associations in the state to develop opioid prescribing guidelines for their professions by 2019. This 4 page document briefly explains the guidelines developed for dentists.
Funding Source: Washington State Department of Health
The Washington legislature directed the medical associations in the state to develop opioid prescribing guidelines for their professions by 2019. This 4 page document briefly explains the guidelines developed for advanced registered nurse practitioners.
Funding Source: Washington State Department of Health
The Washington legislature required all 5 medical licensing boards to develop opioid prescribing guidelines by January 1, 2019. This 4 page document provides information for prescribers on jointly prescribing naloxone with opioid prescriptions and includes a summary of the prescribing guideline requirements on naloxone for nurses, dentists, allopathic physicians, osteopathic physicians, and podiatrists.
Funding Source: Washington State Department of Health
This 2 page document provides a brief overview of the development of opioid prescribing guidelines in Washington state. In 2017, the legislature directed the state’s 5 health care prescribing boards and commissions (medical, dental, nursing, osteopathic, and podiatric) to adopt opioid prescribing guidelines. This document summarizes the guideline development process and compares the 5 guidelines Continue reading
In 2015 the Oregon Health Authority launched it’s Opioid Initiative, an integrated effort to address patient care and safety and population health during the opioid crisis. The initiative included public and private stakeholders engaged in 4 projects described in this report: a Continue reading
These 2016 guidelines from the West Virginia Attorney General’s provide recommendations for health care providers prescribing opioids for their patients. The best practice recommendations cover how to check West Virginia’s Controlled Substance Monitoring Program, how to Continue reading
These 2016 guidelines from the West Virginia Attorney General’s provide recommendations for pharmacists dispensing prescriptions for opioids for pain. The best practice recommendations cover how to check West Virginia’s Controlled Substance Monitoring Program, how to verify legitimacy of the patient and prescription, how to evaluate the safety and appropriateness of the Continue reading
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from West Virginia’s PDMP Continue reading
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from Washington’s PDMP Continue reading